Latest News in the Life Sciences Industry
GlobeNewswire
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting
02 Jul 2026
GlobeNewswire
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
02 Jul 2026
GlobeNewswire
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
02 Jul 2026
GlobeNewswire
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
02 Jul 2026
PR Newswire Association LLC.
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
01 Jul 2026
GlobeNewswire
Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
01 Jul 2026
GlobeNewswire
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease
30 Jun 2026
PR Newswire Association LLC.
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
30 Jun 2026
GlobeNewswire
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
30 Jun 2026
GlobeNewswire
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
30 Jun 2026
GlobeNewswire
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
29 Jun 2026
GlobeNewswire
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
29 Jun 2026
PR Newswire Association LLC.
International Health Innovation & Exchange Association (IHIEA) Launches in Hong Kong and Unveils Six-Point Action Blueprint
29 Jun 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan